Reviews/Books

1. Müller WE, Kirsch C, Eckert GP. 
Membrane-disordering effects of ß-amyloid peptides.
Biochemical Society Transactions. 2001, 29: 617-623.

2. Eckert GP, Kirsch C, Müller WE.
Brain – membrane cholesterol in Alzheimer’s disease.
J Nutr Health Aging. 2003, 1:18-23.

3. Wood WG, Eckert GP, Igbavboa U, Müller WE.
Amyloid beta-peptide interactions with membranes and cholesterol: causes or casualties of Alzheimer' disease.
BBA – Biomembranes. 2003, 1610:281-90.

4. Kirsch C, Eckert GP, Müller WE.
Brain cholesterol statins and Alzheimer’s disease.
Pharmacopsychiatry. 2003, 36: S113-S119.

5. Schaffer S, Müller WE, Eckert GP. 
Tocotrienols: Constitutional effects in aging and disease.
J Nutr. 2005, 135: 151-154.

6. Schmitt-Schillig S, Schaffer S, Weber CC, Eckert GP, Müller WE. 
Flavonoids and the aging brain.
J Physiol Pharmacol. 2005, 56 (Suppl 1):23-36.

7. Heinrich M, Leonti M, Nebel S, Peschel W, Pieroni A, Smith F, Rivera D, Obon C, Inocencio C, Verde A, Fajardo J, Llorach R, Muller WE , Eckert GP, Schaffer S ,Schmitt-Schillig S, Guzdek A, Kapiszewska M.
Understanding local Mediterranean diets: A multidisciplinary pharmacological and ethnobotanical approach.
Pharmacol Res. 2005, 52 (4): 353-366.

8. Wood WG, Igbavboa U, Eckert GP, Johnson-Anuna LN, Franke C, Müller WE.
Is hypercholesterolemia a risk factor for Alzheimer's disease?
Mol Neurobiol. 2005, 31(1-3):185-92.

9. Eckert GP, Wood WG, Müller WE.
Statins: Drugs for Alzheimer’s disease?
J Neural Transm. 2005, 112: 1057 – 1071.

10. Schaffer S, Eckert GP, Schmitt-Schillig S, Müller WE.
Plant foods and brain aging: A critical appraisal.
Forum Nutr. 2006, 59: 86-115.

11. Eckert GP, Müller WE, Wood WG.
Cholesterol lowering drugs and Alzheimer’s disease.
Future Lipidology, 2007, 2(4): 423-432.

12. Eckert GP.
Spezial – Sekundäre Pflanzenstoffe:
Mediterrane Ernährung zur Prophylaxe der Alzheimer Demenz.
Ernährungsumschau, 2008, 55(8): 480-485.

13. Eckert GP.
Manipulation of lipid rafts in neuronal cells.
The Open Biology Journal. 2010, 3: 32-38.

14. Müller WE, Eckert A, Kurz C, Eckert GP, Leuner K.
Mitochondrial dysfunction: common final pathway in brain aging and Alzheimer's disease-therapeutic aspects.
Mol Neurobiol. 2010, 41(2-3):159-71.

15. Hooff GP, Wood WG, Müller WE, Eckert GP.
Isoprenoids, small GTPases and Alzheimer`s disease.
Biochem Biophys Acta. 2010, 1801: 896–905

16. Eckert GP, Wood WG, Müller WE
Lipid membranes and beta-amyloid peptides: A harmful connection.
Curr Protein Pept Sci. 2010, 11(5)5: 319-25.

17. Wood WG, Igbavboa U, Eckert GP, Müller WE.
Statins and neuroprotection: A prescription to the field forward.
Ann NY Acad Sci. 2010, 1199:69-76. 

18. Eckert GP.
Traditional used plants against cognitive decline and Alzheimer’s disease.
Front Ethnopharm. 2010, 1:138. doi: 10.3389/fphar.2010.00138.

19. Wood WG, Igbavboa U, Müller WE, Eckert GP.
Cholesterol asymmetry in synaptic plasma membranes.
J Neurochem. 2011, 116(5):684-9.

20. Eckert GP, Renner K, Eckert SH, Eckmann J, Hagl S, Abdel-Kader RM, Kurz C, Leuner K, Muller WE.
Mitochondrial dysfunction – A pharmacological target in Alzheimer`s disease.
Mol Neurobiol. 2012, 46(1):136-50.

21. Frank J, Chin XW, Schrader C, Eckert GP, Rimbach G.
Do tocotrienols have potential as neuroprotective dietary factors?
Ageing Res Rev. 2012, 11:163-80

22.  Schaffer S, Asseburg H, Kuntz S, Muller WE, Eckert GP
Effect of polyphenols on brain aging and Alzheimer’s disease: Focus on mitochondria
Mol Neurobiol. 2012, 46(1):161-78

23. Schaefer E, Gattaz F, Eckert GP
Alterations of brain membranes in Schizophrenia: Impact of phospholipase A2
Curr Top Med Chem. 2012, 
12(21):2314-23.

24. Eckert GP, Lipka U, Muller WE
Omega-3 Fatty acids in Neurodegenerative Diseases: Focus on Mitochondria
Prostaglandins, Leukotrienes & Essential Fatty Acids, 
2013, 45(1):76-80.

25. Wood WG, Igbavboa U, Muller WE, Eckert GP
Statins, Bcl-2, and Apoptosis: Cell Death or Cell Protection?
Mol Neurobiol. 2013, 48:308–314

26. Wood WG, Mΰller WE, Eckert GP.
Statins and Neuroprotection: Basic Pharmacology Needed.
Mol Neurobiol. 2014 , in press

27. Yang X, Sun GY, Eckert GP, Lee JC.
Cellular Membrane Fluidity in Amyloid Precursor Protein Processing.
Mol Neurobiol. 2014, in press 

28. Hagl S, Asseburg H, Eckert GP
Nutritional approaches for healthy aging of the brain and the prevention of neurodegenerative diseases
In: Pharma Nutrition - An Overview (Eds. Garssen, J; Folkerts G), Springer, Stuttgart, 2014, ISBN 978-3-319-06150-4

29. Eckert GP.
Nutrition and ADHS [in German]
Pharmakon, 2014, 2(1):60-69

30. Friedland-Leuner K, Stockburger C, Denzer I, Eckert GP, Müller WE.
Mitochondrial dysfunction: cause and consequence of Alzheimer's disease.
Prog Mol Biol Transl Sci. 2014;127:183-210

31. Eckert GP.
Designer drugs to improve mental performance.
Pharmakon, 2015, 3(3):218-244 [in German]

32. Eckert GP
The ethnopharmacology of the food-medicine interface: The example of marketing traditional products in Europe.
In: Ethnopharmacology - a Reader (Eds. Heinrich M, Jaeger A), John Wiley & Sons, 2015, ISBN 1118930738 

33. Muller WE, Eckert A, Eckert GP, Fink H, Friedland K, Horr R, Ihl R, Kasper S, Moller HJ.
Ginkgo-Spezialextrakt 761 (Tebonin) - Ein präklinisches und klinisches Update im Wandel klinischer und aetiopathogenetischer Konzepte der Alzheimer-Demenz.
Psychopharmakotherapie, 2016, 23(3)102-19 [in German]

34. Calabrese V, Giordano J, Mancuso C, Di Mauro P, Eckert G, Calabrese EJ. Major Pathogenic Mechanisms in Vascular Cognitive Impairment
J Neurosci Res, 2016, 94(12):1588-1603.

35. Müller WE, Eckert A, Eckert G, Fink H, Friedland K, Gauthier S, Hoerr R, Ihl R, Kasper S, Möller HJ.
Therapeutic efficacy of the ginkgo special extract EGb761® within the framework of the mitochondrial cascade hypothesis of Alzheimer’s disease.
World Journal Biological Psychiatry, 2017,
 doi: 10.1080/15622975.2017.1308552. 

© Prof. Dr. Gunter P. Eckert 2017